| Composition | Dapagliflozin 10mg Metformin 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
DAPACOP M 10/500 Tablets
DAPACOP M 10/500 is a prescription medicine that combines Metformin 500 mg and Dapagliflozin 10 mg, designed to manage type 2 diabetes mellitus. This combination works by improving blood sugar control through two complementary mechanisms: Metformin reduces glucose production in the liver and improves insulin sensitivity, while Dapagliflozin increases glucose excretion through urine by inhibiting SGLT2 in the kidneys.
Doctors commonly prescribe DAPACOP M 10/500 for patients whose blood sugar levels are not adequately controlled by diet, exercise, or single-drug therapy. The combination helps maintain healthy blood glucose levels, reduces the risk of diabetes-related complications such as kidney damage, cardiovascular issues, and nerve problems, and supports overall metabolic health.
The tablet should be taken once daily, preferably with meals, as directed by a physician. Patients are advised to follow a balanced diet, maintain regular exercise, and monitor blood sugar levels frequently. It is important not to skip doses or stop the medication without medical guidance.
Some common side effects may include mild nausea, urinary tract infections, or gastrointestinal discomfort. With proper supervision, DAPACOP M 10/500 provides effective and safe management of type 2 diabetes, helping patients maintain long-term health and quality of life.
